Medical Treatment of Obstructive Sleep Apnea in Children

Creative Commons License

ERGENEKON A. P., GÖKDEMİR Y., Ersu R.

Journal of Clinical Medicine, cilt.12, sa.15, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 15
  • Basım Tarihi: 2023
  • Doi Numarası: 10.3390/jcm12155022
  • Dergi Adı: Journal of Clinical Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Directory of Open Access Journals
  • Anahtar Kelimeler: anti-inflammatory treatment, children, high flow nasal cannula, medical treatment, obstructive sleep apnea, PAP therapy, persistent obstructive sleep apnea
  • Marmara Üniversitesi Adresli: Evet

Özet

Obstructive sleep apnea (OSA) is characterized by recurrent complete or partial obstruction of the upper airway. The prevalence is 1–4% in children aged between 2 and 8 years and rising due to the increase in obesity rates in children. Although persistent OSA following adenotonsillectomy is usually associated with obesity and underlying complex disorders, it can also affect otherwise healthy children. Medical treatment strategies are frequently required when adenotonsillectomy is not indicated in children with OSA or if OSA is persistent following adenotonsillectomy. Positive airway pressure treatment is a very effective modality for persistent OSA in childhood; however, adherence rates are low. The aim of this review article is to summarize medical treatment options for OSA in children.